Sickle Cell Disease

The Sickle Cell Disease pipeline: 17 tracked drugs, 7 approved for this indication.

7 approved / phase 42 Phase 32 Phase 23 Phase 1/23 Phase 1

Compare the share prices of listed companies in Sickle Cell Disease →

Total attributable cost

$3.4B

$34,477/patient

Drug spend

Not yet sourced

How this is calculated ↗

any · US

The Sickle Cell Disease pipeline

← all assets